Literature DB >> 1903931

Uptake and degradation of human low-density lipoprotein by human liver parenchymal and Kupffer cells in culture.

J A Kamps1, J K Kruijt, J Kuiper, T J Van Berkel.   

Abstract

The association with and degradation by cultured human parenchymal liver cells and human Kupffer cells of human low-density lipoprotein (LDL) was investigated in order to define, for the human situation, the relative abilities of the various liver cell types to interact with LDL. With both human parenchymal liver cells and Kupffer cells the association of LDL with the cells followed saturation kinetics which were coupled to LDL degradation. The association of LDL (per mg of cell protein) to both cell types was comparable, but the association with human Kupffer cells was much more efficiently coupled to degradation than was the case in parenchymal cells. The capacity of human Kupffer cells to degrade LDL was consequently 18-fold higher (per mg of cell protein) than that of the human parenchymal liver cells. Competition studies showed that unlabelled LDL competed efficiently with the cell association and degradation of 125I-labelled LDL with both parenchymal and Kupffer cells, while unlabelled acetyl-LDL was ineffective. The degradation of LDL by parenchymal and Kupffer cells was blocked by chloroquine and NH4Cl, indicating that it occurs in the lysosomes. Binding and degradation of LDL by human liver parenchymal cells and human Kupffer cells appeared to be completely calcium-dependent. It is concluded that the association and degradation of LDL by human Kupffer and parenchymal liver cells proceeds through the specific LDL receptor, whereas the association of LDL to Kupffer cells is more efficiently coupled to degradation. The presence of the highly active LDL receptor on human Kupffer cells might contribute significantly to LDL catabolism by human liver, especially under conditions whereby the LDL receptor on parenchymal cells is down-regulated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903931      PMCID: PMC1151155          DOI: 10.1042/bj2760135

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Regulation of low density lipoprotein receptor activity in primary cultures of human hepatocytes by serum lipoproteins.

Authors:  L M Havekes; H Verboom; E de Wit; S H Yap; H M Princen
Journal:  Hepatology       Date:  1986 Nov-Dec       Impact factor: 17.425

2.  High-affinity association and degradation of 125I-labelled low density lipoproteins by human hepatocytes in primary culture.

Authors:  V A Kosykh; S N Preobrazhensky; V O Ivanov; V P Tsibulsky; V S Repin; V N Smirnov
Journal:  FEBS Lett       Date:  1985-04-08       Impact factor: 4.124

Review 3.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

4.  Quantitative role of parenchymal and non-parenchymal liver cells in the uptake of [14C]sucrose-labelled low-density lipoprotein in vivo.

Authors:  L Harkes; J C Van Berkel
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

5.  Uptake of LDL in parenchymal and non-parenchymal rabbit liver cells in vivo. LDL uptake is increased in endothelial cells in cholesterol-fed rabbits.

Authors:  M S Nenseter; R Blomhoff; C A Drevon; G M Kindberg; K R Norum; T Berg
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

6.  Effects of preincubation of primary monolayer cultures of rat hepatocytes with low- and high-density lipoproteins on the subsequent binding and metabolism of human low-density lipoprotein.

Authors:  A M Salter; M Bugaut; J Saxton; S C Fisher; D N Brindley
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

7.  Isolation and culture of Kupffer cells from human liver. Ultrastructure, endocytosis and prostaglandin synthesis.

Authors:  A Brouwer; R J Barelds; A M de Leeuw; E Blauw; A Plas; S H Yap; A M van den Broek; D L Knook
Journal:  J Hepatol       Date:  1988-02       Impact factor: 25.083

8.  Cultured human hepatocytes. Evidence for metabolism of low density lipoproteins by a pathway independent of the classical low density lipoprotein receptor.

Authors:  S B Edge; J M Hoeg; T Triche; P D Schneider; H B Brewer
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

9.  Metabolism of low-density lipoproteins by cultured hepatocytes from normal and homozygous familial hypercholesterolemic subjects.

Authors:  J M Hoeg; S B Edge; S J Demosky; T E Starzl; T Triche; R E Gregg; H B Brewer
Journal:  Biochim Biophys Acta       Date:  1986-05-21

10.  Hepatic processing of the cholesteryl ester from low density lipoprotein in the rat.

Authors:  J F Nagelkerke; H F Bakkeren; F Kuipers; R J Vonk; T J van Berkel
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

View more
  5 in total

1.  Liver cancer targeting of Doxorubicin with reduced distribution to the heart using hematoporphyrin-modified albumin nanoparticles in rats.

Authors:  Ji-Eun Chang; Won-Sik Shim; Su-Geun Yang; Eun-Young Kwak; Saeho Chong; Dae-Duk Kim; Suk-Jae Chung; Chang-Koo Shim
Journal:  Pharm Res       Date:  2011-10-05       Impact factor: 4.200

2.  A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice.

Authors:  Ahmed M Abu-Dief; Mosa Alsehli; Aziz Awaad
Journal:  Histochem Cell Biol       Date:  2022-02-14       Impact factor: 4.304

3.  Low-density lipoproteins are degraded in HepG2 cells with low efficiency.

Authors:  P Lombardi; M Mulder; E de Wit; T J van Berkel; R R Frants; L M Havekes
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

4.  Intracellular events in the assembly of very-low-density-lipoprotein lipids with apolipoprotein B in isolated rabbit hepatocytes.

Authors:  I J Cartwright; J A Higgins
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

5.  PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia.

Authors:  Ivan H Chan; Dennis Van Hoof; Marina Abramova; Melissa Bilardello; Elliot Mar; Brett Jorgensen; Scott McCauley; Harminder Bal; Martin Oft; Peter Van Vlasselaer; John B Mumm
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.